<DOC>
	<DOCNO>NCT01972477</DOCNO>
	<brief_summary>This parallel , 3-arm , randomize , prospective , placebo-controlled , double-blind clinical study eight week therapy investigate clinical efficacy DLBS1449 elevate high density lipoprotein ( HDL ) cholesterol diabetic patient . The hypothesis interest study : administration DLBS1449 elevate HDL-cholesterol level baseline end study significantly high elevation result placebo . In addition , administration DLBS1449 dose 150 mg daily provide significantly good response lower dose ( DLBS1449 75 mg daily ) .</brief_summary>
	<brief_title>DLBS1449 Diabetic Patients With Low HDL</brief_title>
	<detailed_description>There three group treatment dosage regimen study . Eligible subject randomize receive follow regimen : 1 ) DLBS1449 dose 1 x 75 mg daily , 2 ) DLBS1449 dose 1 x 150 mg ( two capsule DLBS1449 75 mg ) daily ; 3 ) placebo , daily . Study medication administer daily , even meal , eight week . Clinical laboratory examination evaluate investigational drug 's efficacy safety perform baseline interval four week 8-week course therapy .</detailed_description>
	<criteria>Male female 21 70 year . Have diagnose diabetes mellitus treated lifestyle intervention least 1 month prior screening , without antidiabetic agent . HDLcholesterol level &lt; 35 mg/dL . Triglycerides level &lt; 200 mg/dL . Adequate liver renal function . Statin and/or fenofibrate therapy regularly take &gt; =3 month stable dose ( ONLY subject currently statin and/or fenofibrate therapy ) . Able take oral medication . Pregnant breastfeed woman willing pregnant . Symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia . Uncontrolled hypertension ( SBP &gt; 160 mmHg and/or DBP &gt; 100 mmHg ) . Any disease state , include chronic/acute systemic infection , uncontrolled illness chronic disease , judge investigator , could interfere trial participation trial evaluation . Concurrent treatment systemic corticosteroid herbal ( alternative ) medicine . Known allergic hypersensitive drug contain similar active substance study medication . Participation clinical study within 30 day prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>DLBS1449</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>HDL-cholesterol</keyword>
</DOC>